ロード中...
Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma
BACKGROUND: Lung cancer is the leading cause of cancer-related mortality worldwide. Low-dose CT (LDCT) imaging is now recommended to screen high-risk lung cancer individuals in the USA. LDCT has resulted in increased detection of stage I lung cancer for which the current standard of care is surgery...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5522266/ https://ncbi.nlm.nih.gov/pubmed/28402963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16784 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|